Hypersensitivity to the vaccine & gelatin. History of anaphylactoid reaction to neomycin. Blood dyscrasias, leukemia, lymphomas of any type, other malignant neoplasms affecting bone marrow or lymphatic system. Immunosuppressive therapy (including high-dose corticosteroids). Primary & acquired immunodeficiency states including immunosupression in association w/ AIDS or other clinical manifestations of infection w/ HIV. Family history of congenital or hereditary immunodeficiency. Active untreated TB & any active febrile illness w/ fever >38.5°C. Pregnancy (avoid for 3 mth following vaccination in postpuberty in females).
Do not inj IV. Anaphylactoid reactions. HIV patients w/ & w/o evidence of immunosuppression. Avoid close contact w/ susceptible high-risk patients (eg, immunocompromised individuals, pregnant women & their newborn infants w/o documented history of chickenpox or lab evidence of prior infection) for up to 6 wk. Defer vaccination for at least 5 mth following blood/plasma transfusions or administration of Ig or varicella zoster Ig (VZIG); or do
not give any Ig including VZIG 2 mth thereafter. Avoid pregnancy for 3 mth following vaccination. Lactation. Childn <1 yr. Not recommended for infant <12 mth.